(Press-News.org) An investigational treatment for Marfan syndrome is as effective as the standard therapy at slowing enlargement of the aorta, the large artery of the heart that delivers blood to the body, new research shows. The findings indicate a second treatment option for Marfan patients, who are at high risk of sudden death from tears in the aorta.
The results are being presented Nov. 18 at the American Heart Association's annual meeting in Chicago and will appear online the same day in the New England Journal of Medicine.
"For years, standard medical therapy for Marfan syndrome consisted of giving patients beta blockers, which lower heart rate and blood pressure, reducing stress on the wall of the aorta," said study co-author Alan C. Braverman, MD, a cardiologist at Washington University School of Medicine in St. Louis. "This new study suggests that we have a second option for patients that appears to be as effective as standard treatment."
The second option is Losartan, an angiotensin receptor blocker. Past research in mice and smaller clinical trials suggested that this class of drugs might actually be superior to beta blocker treatment for Marfan syndrome. Angiotensin receptor blockers commonly are prescribed to treat high blood pressure.
People with Marfan syndrome have weak connective tissues and tend to develop unusually long arms, legs and fingers. In addition to heart problems, patients often develop problems with the eyes, lungs, bones and joints. Patients with the condition are at high risk of sudden death from a tear in the aorta, also called an aortic dissection.
Though there is no cure for Marfan syndrome, treatment with beta blockers and preventive surgery to replace the section of the aorta adjacent to the heart has increased lifespan to near normal. But physicians have continued to look for more effective therapies, especially since some patients on beta blockers experience side effects such as tiredness and nausea.
So investigators in the Pediatric Heart Network of the National Institutes of Health (NIH), including Braverman and senior author Ronald V. Lacro, MD, a cardiologist at Harvard Medical School and Boston Children's Hospital, conducted a clinical trial comparing the beta blocker Atenolol with Losartan.
The study included 608 patients with Marfan syndrome at 21 medical centers nationwide. Patients were ages 6 months to 25 years and had enlarged aortas. Half of these participants were randomly given Losartan, the investigational treatment, and the other half received Atenolol, the standard therapy, but in higher doses than physicians typically prescribe to see if this would increase the beta blocker's effectiveness.
After following participants for three years, the investigators reported no differences between the two groups in the growth rate of the aorta. They further observed similar rates of tears in the aorta, similar numbers of surgeries required to repair these tears and no difference in the number of deaths between the two groups.
"This trial demonstrated that Marfan patients treated with either Atenolol or Losartan had very slow rates of aortic growth, and each group tolerated their medications well," said Braverman, who treats patients at Barnes-Jewish Hospital. "While beta blockers may be the gold standard for this condition, these results suggest we must use effective doses. This is also an important alternative therapy for the smaller number of patients who are intolerant to beta blockers."
Braverman also pointed out that ongoing research, including clinical trials currently underway, will continue to shed light on the different effects of these drugs. Investigators would like to determine whether factors such as a patient's genetic makeup, age and severity of disease favor one drug over the other, or a combination of the two.
INFORMATION:
This work was supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH), grant numbers U01 HL068269, U01 HL068270, U01 HL068279, U01 HL068281, U01 HL068285, U01 HL068292, U01 HL068290, U01 HL068288 and U01 HL085057, and the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development. Additional support provided by The Marfan Foundation, Merck & Co. Inc., and Teva Canada Limited.
Lacro RV, et al for the Pediatric Heart Network Investigators. Atenolol versus Losartan in children and young adults with Marfan syndrome. The New England Journal of Medicine. Nov. 18, 2014.
Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
Each cell contains thousands of proteins, each one of which bears a unique signature. All proteins, distinct in shape and function, are built from the same amino acid strings. Many proteins are vital, as evidenced by the plethora of diseases linked to their absence or malfunction. But how exactly did proteins first come to be? Do they all share a single common ancestor? Or did proteins evolve from many different origins?
Forming a global picture of the protein universe is crucial to addressing these and other important questions, but it's nearly impossible to do. Such ...
URBANA, Ill. - Most Americans don't get the daily recommended amount of fiber in their diet, though research has shown that dietary fiber can cause a shift in the gut toward beneficial bacteria, reducing the risk of colon cancer, type 2 diabetes, and other diseases. A new study from the University of Illinois shows that two specific functional fibers may also have the potential to assist in weight loss when made part of a long-term, daily diet.
Kelly Swanson, a U of I professor of nutrition, and his team had previously been able to see a "snapshot" of what bacteria were ...
When NASA's Terra satellite passed over the Southern Indian Ocean, the MODIS instrument aboard captured a picture of Tropical Cyclone Adjali that showed it developed a "tail," which is actually band of thunderstorms extending south of the center.
The Moderate Resolution Imaging Spectroradiometer, or MODIS instrument that flies aboard NASA's Terra satellite took a visible picture of Tropical Storm Adjali on Nov. 18 at 05:35 UTC (12:35 a.m. EST). The MODIS image showed a concentration of strong storms around the center of Adjali's circulation and a band of thunderstorms ...
A peek inside the brains of professional musicians has given University of Texas at Arlington psychology researchers what may be the first links between music expertise and advantages in long-term memory.
Heekyeong Park, assistant professor of psychology, and graduate student James Schaeffer used electroencephalography (EEG) technology to measure electrical activity of neurons in the brains of 14 musicians and 15 non-musicians and noted processing differences in the frontal and parietal lobe responses. The team will present initial results of their new research Tuesday ...
Motor vehicle crashes are the most common cause of unintentional life lost around the world, with about 30,000 deaths occurring annually in the U.S. due to motor-vehicle crashes.
A study by a doctoral student in epidemiology at the Indiana University Richard M. Fairbanks School of Public Health at Indiana University-Purdue University Indianapolis showed that vehicle inequities have a significant impact on survivability in head-on collisions.
Uzay Kirbiyik conducted a study of risk factors associated with drivers' survival in head-on vehicle collisions by examining ...
Chicago, November 18, 2014--The Associated Press-NORC Center for Public Affairs Research has released an issue brief containing results of a survey about Hispanics' experiences with long-term care in the United States. The issue brief provides new data on how Hispanics age 40 and older are, or are not, planning for long-term care, details how their experiences compare to those of non-Hispanics, and highlights ways in which demographic differences among Hispanics affect their experiences. The study also addresses how Hispanics' familial relationships are impacted by providing ...
This news release is available in French. Montreal, November 18, 2014 -- The next time you berate yourself for wasting an evening playing Farmville on Facebook, think again. If you were playing with Mom, Dad or Aunt Carmen, you were actually helping to strengthen family bonds.
New research from Concordia University, published in Information, Communication and Society, shows that, beyond being a fun distraction, social network games (SNGs) can offer family members a meaningful way to interact and meet social obligations.
"Maintaining those connections is especially ...
URBANA, Ill. - If an in-the-flesh Extension specialist isn't available to provide training, is a video of the specialist's presentation or a video of a new agricultural practice a good substitute? The answer, according to a University of Illinois study with farmers in rural Uganda, isn't simple, particularly when gender is factored into the equation.
"The literature in the field says communication materials like videos work best to support face-to-face communication," said U of I agricultural communications professor Lulu Rodriguez. "But if you don't have an Extension ...
CHICAGO - An important new study of men who have undergone testosterone replacement therapy has found that taking supplemental testosterone does not increase their risk of experiencing a major adverse cardiac event, such as a heart attack or stroke.
Researchers at the Intermountain Medical Center Heart Institute in Murray, Utah, which is the flagship facility for the Intermountain Healthcare system, studied 5,695 men between the ages of 53 and 71. The men, all patients at Intermountain Healthcare hospitals, had initial low testosterone levels.
Researchers found that ...
WASHINGTON, DC - November 18, 2014 - Certain subtypes of avian influenza viruses have the potential to cause more severe disease in humans than other avian influenza subtypes and should be monitored carefully to prevent spread of disease, according to a study published this week in mBio®, the online open-access journal of the American Society for Microbiology.
The work, directed by researchers at the National Institute of Allergy and Infectious Diseases in Bethesda, Md., found that flu viruses expressing the low pathogenicity avian H1, H6, H7, H10 or H15 hemagglutinins ...
